Literature DB >> 26794869

The kinase activity of PKR represses inflammasome activity.

Howard C H Yim1,2, Die Wang1,2, Liang Yu3,2, Christine L White1,2, Pieter W Faber4, Bryan R G Williams1,2, Anthony J Sadler1,2.   

Abstract

The protein kinase R (PKR) functions in the antiviral response by controlling protein translation and inflammatory cell signaling pathways. We generated a transgenic, knock-in mouse in which the endogenous PKR is expressed with a point mutation that ablates its kinase activity. This novel animal allows us to probe the kinase-dependent and -independent functions of PKR. We used this animal together with a previously generated transgenic mouse that is ablated for PKR expression to determine the role of PKR in regulating the activity of the cryopyrin inflammasome. Our data demonstrate that, in contradiction to earlier reports, PKR represses cryopyrin inflammasome activity. We demonstrate that this control is mediated through the established function of PKR to inhibit protein translation of constituents of the inflammasome to prevent initial priming during innate immune signaling. These findings identify an important role for PKR to dampen inflammation during the innate immune response and caution against the previously proposed therapeutic strategy to inhibit PKR to treat inflammation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26794869      PMCID: PMC4783464          DOI: 10.1038/cr.2016.11

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  32 in total

1.  Non-canonical inflammasome activation targets caspase-11.

Authors:  Nobuhiko Kayagaki; Søren Warming; Mohamed Lamkanfi; Lieselotte Vande Walle; Salina Louie; Jennifer Dong; Kim Newton; Yan Qu; Jinfeng Liu; Sherry Heldens; Juan Zhang; Wyne P Lee; Merone Roose-Girma; Vishva M Dixit
Journal:  Nature       Date:  2011-10-16       Impact factor: 49.962

2.  The N-terminus of PKR is responsible for the activation of the NF-kappaB signaling pathway by interacting with the IKK complex.

Authors:  Marion C Bonnet; Caroline Daurat; Catherine Ottone; Eliane F Meurs
Journal:  Cell Signal       Date:  2006-02-28       Impact factor: 4.315

3.  The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis.

Authors:  S B Lee; M Esteban
Journal:  Virology       Date:  1994-03       Impact factor: 3.616

4.  Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation.

Authors:  James E Vince; W Wei-Lynn Wong; Ian Gentle; Kate E Lawlor; Ramanjaneyulu Allam; Lorraine O'Reilly; Kylie Mason; Olaf Gross; Stephen Ma; Greta Guarda; Holly Anderton; Rosa Castillo; Georg Häcker; John Silke; Jürg Tschopp
Journal:  Immunity       Date:  2012-02-24       Impact factor: 31.745

5.  Type I interferon inhibits interleukin-1 production and inflammasome activation.

Authors:  Greta Guarda; Marion Braun; Francesco Staehli; Aubry Tardivel; Chantal Mattmann; Irmgard Förster; Matthias Farlik; Thomas Decker; Renaud A Du Pasquier; Pedro Romero; Jürg Tschopp
Journal:  Immunity       Date:  2011-02-25       Impact factor: 31.745

6.  Translational regulation by the interferon-induced double-stranded-RNA-activated 68-kDa protein kinase.

Authors:  G N Barber; M Wambach; M L Wong; T E Dever; A G Hinnebusch; M G Katze
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

7.  C/EBP homologous protein (CHOP) is crucial for the induction of caspase-11 and the pathogenesis of lipopolysaccharide-induced inflammation.

Authors:  Motoyoshi Endo; Masataka Mori; Shizuo Akira; Tomomi Gotoh
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

8.  Characterization of transgenic mice with targeted disruption of the catalytic domain of the double-stranded RNA-dependent protein kinase, PKR.

Authors:  N Abraham; D F Stojdl; P I Duncan; N Méthot; T Ishii; M Dubé; B C Vanderhyden; H L Atkins; D A Gray; M W McBurney; A E Koromilas; E G Brown; N Sonenberg; J C Bell
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

9.  Initial description of the human NLRP3 promoter.

Authors:  J P Anderson; J L Mueller; A Misaghi; S Anderson; M Sivagnanam; R D Kolodner; H M Hoffman
Journal:  Genes Immun       Date:  2008-08-21       Impact factor: 2.676

Review 10.  Interferon-inducible antiviral effectors.

Authors:  Anthony J Sadler; Bryan R G Williams
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

View more
  18 in total

1.  Mechanism of Protein Kinase R Inhibition by Human Cytomegalovirus pTRS1.

Authors:  Heather A Vincent; Benjamin Ziehr; Nathaniel J Moorman
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

2.  A human cellular noncoding RNA activates the antiviral protein 2'-5'-oligoadenylate synthetase 1.

Authors:  Brenda M Calderon; Graeme L Conn
Journal:  J Biol Chem       Date:  2018-08-20       Impact factor: 5.157

3.  NLRP12 negatively regulates proinflammatory cytokine production and host defense against Brucella abortus.

Authors:  Tatiana N Silveira; Marco Túlio R Gomes; Luciana S Oliveira; Priscila C Campos; Gabriela G Machado; Sergio C Oliveira
Journal:  Eur J Immunol       Date:  2016-12-05       Impact factor: 5.532

Review 4.  Signaling pathways and intervention therapies in sepsis.

Authors:  Yun-Yu Zhang; Bo-Tao Ning
Journal:  Signal Transduct Target Ther       Date:  2021-11-25

5.  DDX17 is an essential mediator of sterile NLRC4 inflammasome activation by retrotransposon RNAs.

Authors:  Shao-Bin Wang; Siddharth Narendran; Shuichiro Hirahara; Akhil Varshney; Felipe Pereira; Ivana Apicella; Meenakshi Ambati; Vidya L Ambati; Praveen Yerramothu; Kameshwari Ambati; Yosuke Nagasaka; Dionne Argyle; Peirong Huang; Kirstie L Baker; Kenneth M Marion; Kartik Gupta; Bo Liu; David R Hinton; Scott W Canna; Tamer Sallam; Srinivas R Sadda; Nagaraj Kerur; Bradley D Gelfand; Jayakrishna Ambati
Journal:  Sci Immunol       Date:  2021-12-03

Review 6.  Novel aspects of the assembly and activation of inflammasomes with focus on the NLRC4 inflammasome.

Authors:  William G Fusco; Joseph A Duncan
Journal:  Int Immunol       Date:  2018-04-25       Impact factor: 4.823

Review 7.  A tale of two proteins: PACT and PKR and their roles in inflammation.

Authors:  Evelyn Chukwurah; Kenneth T Farabaugh; Bo-Jhih Guan; Parameswaran Ramakrishnan; Maria Hatzoglou
Journal:  FEBS J       Date:  2021-01-15       Impact factor: 5.622

8.  PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation.

Authors:  Min Xie; Yan Yu; Rui Kang; Shan Zhu; Liangchun Yang; Ling Zeng; Xiaofang Sun; Minghua Yang; Timothy R Billiar; Haichao Wang; Lizhi Cao; Jianxin Jiang; Daolin Tang
Journal:  Nat Commun       Date:  2016-10-25       Impact factor: 14.919

9.  Inhibition of the inflammatory response to stress by targeting interaction between PKR and its cellular activator PACT.

Authors:  Stephanie Dabo; Patrick Maillard; Milagros Collados Rodriguez; Marianne Doré Hansen; Sabrina Mazouz; Donna-Joe Bigot; Marion Tible; Geneviève Janvier; Olivier Helynck; Patricia Cassonnet; Yves Jacob; Jacques Bellalou; Anne Gatignol; Rekha C Patel; Jacques Hugon; Hélène Munier-Lehmann; Eliane F Meurs
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

Review 10.  Post-translational regulation of inflammasomes.

Authors:  Jie Yang; Zhonghua Liu; Tsan Sam Xiao
Journal:  Cell Mol Immunol       Date:  2016-06-27       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.